Sector: MedicalTheravance, Inc. (NASDAQ: THRX)
Headlines
- Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
Nov 05, 2009 04:06 PM | THRX
- Theravance to Present at the 18th Annual Credit Suisse Health Care Conference
Nov 03, 2009 04:05 PM | THRX
- Theravance Announces New Employment Inducement Award
Nov 02, 2009 07:45 PM | THRX
- Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Nosocomial Pneumonia and Complicated Skin and Soft Tissue Infections in Europe
Oct 28, 2009 04:30 PM | THRX
- Theravance Reports Third Quarter 2009 Financial Results
Oct 27, 2009 04:05 PM | THRX
- GlaxoSmithKline and Theravance commence Phase III Horizon programme to develop a next-generation treatment for COPD
Oct 27, 2009 08:04 AM | GSK, THRX
- Theravance Earns $20 Million Milestone Under Telavancin Collaboration Agreement
Oct 22, 2009 04:20 PM | THRX
- Theravance to Report Third Quarter 2009 Financial Results on October 27, 2009
Oct 19, 2009 04:05 PM | THRX
- This Fall Will Be Crazy For These Biotech Stocks
Oct 16, 2009 02:55 PM | ACOR, AMGN, CADX, GTXI, THRX, XNPT
- Theravance Announces New Employment Inducement Award
Oct 01, 2009 09:00 PM | THRX
- Big Deals to Reshape Bay Area Biotech
Mar 12, 2009 08:51 PM | AFFY, CVTX, DNA, EXEL, GILD, JEF
- Big Deals Reshape Bay Area Biotech Industry
Mar 12, 2009 11:51 AM | AFFY, CVTX, DNA, EXEL, GILD, PFE
- Theravance Announces New Employment Inducement Awards
Aug 03, 2009 07:15 PM | THRX
- Theravance Reports Second Quarter 2009 Financial Results
Jul 23, 2009 05:01 PM | GSK, THRX
- Theravance to Report Second Quarter 2009 Financial Results on July 23, 2009
Jul 09, 2009 04:05 PM | THRX
- Theravance Announces New Employment Inducement Awards
Jul 01, 2009 08:31 PM | THRX
- Theravance Announces New Employment Inducement Awards
Jun 04, 2009 06:00 PM | THRX
- Theravance to Present at Investor Conferences in June 2009
Jun 02, 2009 04:05 PM | THRX
- Theravance Announces New Employment Inducement Awards
May 04, 2009 08:00 PM | THRX
- Theravance to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
Apr 30, 2009 04:05 PM | THRX
- FDA Accepts for Review Theravance's Complete Response Submission for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections
Apr 24, 2009 04:05 PM | THRX
- Theravance to Webcast 2009 Annual Meeting of Stockholders on April 24, 2009
Apr 16, 2009 04:05 PM | THRX
- Form 4 Brinkley David L For: Sep 15 (10K)
Sep 16, 2009 08:38 PM
- Form 4 Aguiar Michael W For: Sep 13 (10K)
Sep 15, 2009 08:35 PM
- Form 4 Shafer Bradford J For: Aug 20 (10K)
Aug 21, 2009 08:44 PM
- Form 4 Mammen Mathai For: Aug 20 (10K)
Aug 21, 2009 08:44 PM
- Form 4 Brinkley David L For: Aug 20 (10K)
Aug 21, 2009 08:44 PM
- Form 4 BLUM LEONARD M For: Aug 20 (10K)
Aug 21, 2009 08:42 PM
- Form 4 Aguiar Michael W For: Aug 20 (10K)
Aug 21, 2009 08:42 PM
- Form 4 Winningham Rick E For: Aug 20 (10K)
Aug 21, 2009 08:41 PM
- Form 3 Brinkley David L For: Jun 01 (10K)
Jun 11, 2009 09:08 PM
- Form 4 Winningham Rick E For: May 20 (10K)
May 22, 2009 08:33 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
THRX
|
Compare to S&P
|
| YTD |
12.75 %
|
-1.71 %
|
| 4 Weeks |
-1.83 %
|
-2.87 %
|
| 12 Weeks |
-5.03 %
|
-7.39 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 0.00 %
|
|
EPS Growth in Last Year: -2.94 %
|
|
Sales Growth in Last Quarter: 0.40 %
|
|
Sales Growth in Last Quarter: -8.07 %
|
|